Spectrum and potency of ceftaroline against leading pathogens causing community-acquired respiratory tract and skin and soft tissue infections in Latin America, 2010

Spectrum and potency of ceftaroline against leading pathogens causing community-acquired respiratory tract and skin and soft tissue infections in Latin America, 2010

Ceftaroline, the active metabolite of the prodrug ceftaroline fosamil, is a cephalosporin with in vitro bactericidal activity against Gram-positive organisms, including methicillin-susceptible and -resistant Staphylococcus aureus, β-haemolytic and viridans group streptococci, and Streptococcus pneum...

Szczegółowa specyfikacja

Opis bibliograficzny
Główni autorzy:	Robert K. Flamm, Helio S. Sader, Ronald N. Jones
Format:	Artykuł
Język:	English
Wydane:	Elsevier 2013-09-01
Seria:	Brazilian Journal of Infectious Diseases
Dostęp online:	http://www.sciencedirect.com/science/article/pii/S141386701300161X

Podobne zapisy

Ceftaroline activity tested against contemporary Latin American bacterial pathogens (2011)
od: Robert K. Flamm, i wsp.
Wydane: (2014-03-01)

Antimicrobial activity of ceftaroline and comparator agents tested against organisms isolated from patients with community-acquired bacterial pneumonia in Europe, Asia, and Latin America
od: Helio S. Sader, i wsp.
Wydane: (2018-12-01)

Ceftaroline in the management of complicated skin and soft tissue infections and community acquired pneumonia
od: Mpenge MA, i wsp.
Wydane: (2015-04-01)

Activity of ceftaroline and comparators against pathogens isolated from skin and soft tissue infections in Latin America – results of AWARE surveillance 2012
od: Daryl Hoban, i wsp.
Wydane: (2015-11-01)

Ceftaroline Fosamil, a Broad Spectrum Cephalosporin Antibiotic for the Treatment of Community-Acquired Pneumonia and Complicated Skin and Skin Structure Infections
od: A. V. Nikitin
Wydane: (2020-05-01)

Critical appraisal of ceftaroline in the management of community-acquired bacterial pneumonia and skin infections
od: Goodman JJ, i wsp.
Wydane: (2012-03-01)

In vitro activity of ceftaroline against bacterial isolates causing skin and soft tissue and respiratory tract infections collected in Latin American countries, ATLAS program 2016–2020
od: Naglaa Mohamed, i wsp.
Wydane: (2024-03-01)

Increased resistance to first-line agents among bacterial pathogens isolated from urinary tract infections in Latin America: time for local guidelines?
od: Soraya S Andrade, i wsp.
Wydane: (2006-11-01)

Ceftaroline fosamil for the treatment of community-acquired bacterial pneumonia in the intensive care unit
od: Maggiore C, i wsp.
Wydane: (2015-04-01)

Ceftolozane-tazobactam activity against drug-resistant Enterobacteriaceae and Pseudomonas aeruginosa causing healthcare-associated infections in Latin America: report from an antimicrobial surveillance program (2013–2015)
od: Michael A. Pfaller, i wsp.
Wydane: (2017-11-01)

The Constitution – Latin America 2010
od: Delia M. Ferreira Rubio
Wydane: (2010-01-01)

Multicenter assessment of the linezolid spectrum and activity using the disk diffusion and Etest methods: report of the Zyvox® Antimicrobial Potency Study in Latin America (LA-ZAPS)
od: Charles H. Ballow, i wsp.

Multicenter assessment of the linezolid spectrum and activity using the disk diffusion and Etest methods: report of the Zyvox® Antimicrobial Potency Study in Latin America (LA-ZAPS)
od: Ballow Charles H., i wsp.
Wydane: (2002-01-01)

Resistance to ceftaroline - 2018 review
od: Rafał Ślusarczyk, i wsp.
Wydane: (2018-07-01)

In vitro activity of ceftaroline against bacterial pathogens isolated from patients with skin and soft tissue and respiratory tract infections in the Middle East and Africa: AWARE global surveillance programme 2015–2018
od: James A. Karlowsky, i wsp.
Wydane: (2021-03-01)

Real-World Use and Treatment Outcomes of Ceftaroline Fosamil in Patients with Complicated Skin and Soft Tissue Infection: A Multinational Retrospective Study
od: Ferry T, i wsp.
Wydane: (2024-07-01)

A Retrospective Analysis of Probability of Target Attainment in Community-Acquired Pneumonia: Ceftaroline Fosamil Versus Comparators
od: Andrew Cristinacce, i wsp.
Wydane: (2019-04-01)

The use of extrapolation based on modeling and simulation to support high‐dose regimens of ceftaroline fosamil in pediatric patients with complicated skin and soft‐tissue infections
od: Phylinda L.S. Chan, i wsp.
Wydane: (2021-06-01)

In Silico Study of Ceftaroline’s Molecular Properties
od: Elso Manuel Cruz Cruz, i wsp.
Wydane: (2011-03-01)

In Silico Study of Ceftaroline’s Molecular Properties
od: Elso Manuel Cruz Cruz, i wsp.
Wydane: (2011-03-01)

Ceftaroline-related acute eosinophilic pneumonia
od: Zaw Min, i wsp.
Wydane: (2021-01-01)

Characterizing the role of porin mutations in susceptibility of beta lactamase producing Klebsiella pneumoniae isolates to ceftaroline and ceftaroline-avibactam
od: Ali Khalid, i wsp.
Wydane: (2020-04-01)

Antimicrobial susceptibility patterns of unusual nonfermentative gram-negative bacilli isolated from Latin America: report from the SENTRY Antimicrobial Surveillance Program (1997-2002)
od: Ana C Gales, i wsp.
Wydane: (2005-10-01)

In Vitro Activity of Ceftaroline and Comparators against Bacterial Isolates Collected Globally from Patients with Skin and Soft Tissue Infections: ATLAS Program 2019–2020
od: Alona Kuraieva, i wsp.
Wydane: (2023-07-01)

In vitro activity of tigecycline, a new glycylcycline, tested against 1,326 clinical bacterial strains isolated from Latin America
od: Ana C. Gales, i wsp.

Evaluation of in vitro activity of ceftaroline against pathogens associated with community-acquired pneumonia: ATLAS program 2017–2019
od: Eric Utt, i wsp.
Wydane: (2023-06-01)

Ability of Latin America laboratories to detect antimicrobial resistance patterns: experience of the SENTRY antimicrobial surveillance program (1997-2000)
od: Mendes Rodrigo E., i wsp.
Wydane: (2003-01-01)

Ability of Latin America laboratories to detect antimicrobial resistance patterns: experience of the SENTRY antimicrobial surveillance program (1997-2000)
od: Rodrigo E. Mendes, i wsp.

Susceptibility of Clinical Isolates of Staphylococcus aureus to Ceftaroline
od: Harsha Sreedharan, i wsp.
Wydane: (2021-01-01)

In vitro activity of ceftaroline and comparators against bacterial isolates collected globally from patients with skin infections
od: Denis Piérard, i wsp.
Wydane: (2021-09-01)

CELAC in International Relations of Latin America (2010-2023)
od: Regina Andriukaitiene, i wsp.
Wydane: (2024-01-01)

Antimicrobial susceptibility of quinupristin/dalfopristin tested against gram-positive cocci from Latin America: results from the Global SMART (GSMART) surveillance study
od: Sader Helio S., i wsp.
Wydane: (2001-01-01)

8: IN VITRO ACTIVITIES OF CEFTAROLINE AND COMPARATOR AGENTS AGAINST BACTERIAL PATHOGENS FREQUENTLY CAUSING COMMUNITY-ACQUIRED RESPIRATORY TRACT INFECTIONS IN PATIENTS FROM ASIA/PACIFIC: ATLAS SURVEILLANCE PROGRAM 2020
od: Meredith Hackel, Dr., i wsp.
Wydane: (2022-11-01)

Use of Ceftaroline Fosamil in Osteomyelitis: CAPTURE Study Experience
od: Leonard B. Johnson, i wsp.
Wydane: (2019-02-01)

Efficacy and safety of ceftaroline: systematic review and meta-analysis
od: Maria T. Rosanova, i wsp.
Wydane: (2019-01-01)

Of the politicals potencies of the Latin American neo-baroque
od: Alejandra Adela González
Wydane: (2018-08-01)

Clinico-Economic Effectiveness of Ceftaroline Fosamil for the Treatment of Hospitalised Patients with Pneumococcal Community-Acquired Pneumonia from a Societal Perspective
od: Belkova Yu.А., i wsp.
Wydane: (2015-02-01)

Online continuing interprofessional education on hospital-acquired infections for Latin America
od: Julio C. Medina-Presentado, i wsp.
Wydane: (2017-03-01)

Antimicrobial susceptibility of clinical isolates of Stenotrophomonas maltophilia isolates from Europe, Asia, and Latin America (2018-2023)
od: Helio S. Sader, i wsp.
Wydane: (2025-04-01)

Community-genotype methicillin-resistant Staphylococcus aureus skin and soft tissue infections in Latin America: a systematic review
od: Rodrigo Cuiabano Paes Leme, i wsp.
Wydane: (2021-01-01)